Certificate

Brand

NGenebio

Product Type

Reagents

Highlights

Excellent tool for discovering variants associated with solid tumors using a comprehensive approach to next-generation sequencing (NGS)

SOLIDaccuTest™ is an excellent tool for discovering variants associated with solid tumors using a comprehensive approach to next-generation sequencing (NGS). It reflects the latest research trends and is optimized for medical purposes by selecting essential genes of solid tumors including lung, colon, breast, skin brain, stomach and ovarian cancers, etc.

Application
SOLIDACCUTEST™
DNA RNA
CERTIFICATE CE-IVD RUO
TARGET DISEASES Lung, colon, breast, brain, skin, stomach, and ovarian cancers, etc
Combination and capture method
NUMBER 96 tests/kit (8 running times/kit, reach to 12 samples/run)
SAMPLES  FFPE, biopsy tissue
Tumor size %: >20%
TARGET GENES 84 genes 29 genes
 WEIGHT 270 kb 80 kb
RETURNING TIME 3 days 3.5 days
VARIANT SNV, INDEL, CNV* Fusion
 NGS SYSTEM illumina MiSeq, MiSeq Dx / MiSeq Reagent kit, v3, 300 vòng
ANALYSIS SOLUTION NGeneAnalySys™ (CE)

*RUO, Research Use Only

Specifications

Application in detecting 84 DNA genes & 29 mutant RNA genes related to solid tumor cancer.

The test kit is the latest researched and optimized for medical use by selecting essential genes of solid tumors including lung, colon, breast, brain, skin, stomach, and ovarian cancers, etc.

Other information

Supplier

Ngenebio

Related Products

BRCAaccuTest™ & BRCAaccuTest™PLUS

BRCAaccuTest™ PLUS with CE-IVD certificate for HBOC Breast/Ovarian Cancer Test

BRCAaccuTest™ & BRCAaccuTest™PLUS

BRCAaccuTest™ & BRCAaccuTest™PLUS is a regent for producing libraries for
analyzing the BRCA ½ genes using the NGS (next-generation sequencing) method,
which analyzes genomic DNA derived from blood or FFPE tissues.

Next Generation Sequencing System – NovaSeq 6000

Model: NovaSeq 6000
Manufacturer: Illumina/USA
– Scalable platform
Match data output, time to results, and price per sample to study needs
– Flexible performance
Configure sequencing method, flow cell type, and read length to support a broad range of applications
– Streamlined operation
Increase lab efficiency with a simplified workflow and reduced hands-on time

Next-Generation Sequencing System – NextSeq 2000

 The NextSeq 2000 Sequencing System uses patterned flow cells similar to those that power the NovaSeq™ 6000 System. The result is a highly flexible and scalable benchtop system that offers the highest cluster density flow cell of any on-market NGS system to date, driving down the cost per gigabase (Gb) of the sequencing run.

NextSeq 1000 sequencing system

Product Information

Model: NextSeq 1000

Manufacturer: Illumina

Origin: Singapore/United States

Launching year: 01/2020

PANARealTyperTM HPV Kit

PANA RealTyperTM HPV Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.

Next Generation Sequencing System – iSeq 100

Model: iSeq 100
Manufacturer: Illumina/USA
Illumina’s smallest next-generation DNA sequencing system, with small, fast and efficient sequencing throughput, suitable for all labs
– Fast data generation: Suitable for small projects, on a dedicated device, low throughput with fast turnaround times
– Convenient operation: Control the sequencing process from start to finish and ensure independent sequencing instead of outsourcing.

TruSight® Tumor 26

TruSight Tumor 26 Kit includes library preparation reagent set and uses next-generation sequencing (NGS) technology to provide a comprehensive assessment of 26 genes that are commonly related to mutations in solid tumors and somatic variants

TruSight Tumor 26

TruSight Tumor 26 Kit include reagents to prepare for Library preparation samples, sequencing 26 genes relating to solid cancer, variant of  soma in NGS – Next Generation Sequencing of Illumina

Next Generation Sequencing System – MiSeq

Model: MiSeq
Manufacturer: Illumina/USA
– The MiSeq System combines cluster generation, amplification, sequencing and data analysis on a single system
– The system is most widely used, with next-generation sequencing technology –  Sequencing by Synthesis – SBS